1. Interleukin‐36 receptor mediates the crosstalk between plasma cells and synovial fibroblasts. Issue 12 (22nd September 2017) Authors: Schmitt, Verena; Hahn, Madelaine; Kästele, Verena; Wagner, Olga; Wiendl, Maximilian; Derer, Anja; Taddeo, Adriano; Hahne, Stefanie; Radbruch, Andreas; Jäck, Hans‐Martin; Schuh, Wolfgang; Mielenz, Dirk; Gay, Steffen; Schett, Georg; Hueber, Axel J; Frey, Silke Journal: European journal of immunology Issue: Volume 47:Issue 12(2017) Page Start: 2101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0076 JAK-INHIBITORS TOFACITINIB AND BARICITINIB IMPROVE PATHOLOGICAL BONE LOSS IN VIVO. (June 2019) Authors: Adam, Susanne; Simon, Nils; Steffen, Ulrike; Harre, Née; Andes, Fabian; Müller, Dorothea; Culemann, Stephan; Andreev, Darja; Hahn, Madelaine; Scholtysek, Carina; Schett, Georg; Krönke, Gerhard; Frey, Silke; Hueber, Axel Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗